Print this page
Biospecimen Procurement for Cancer Immunotherapy at Rutgers Cancer Institute.
Primary objectives:
- To collect for cancer research biospecimens including blood, apheresis products, tumors, body fluids, and other biospecimens.
- To conduct laboratory research on collected de-identified biospecimens.
Protocol Number:
192002
Phase:
N/A
Applicable Disease Sites:
Any Site
Principal Investigator:
Christian Hinrichs
Scope:
Local
Participating Institutions:
- Rutgers Cancer Institute of New Jersey
- Rutgers Cancer Institute of New Jersey-University Hospital
For further information about clinical trials, please contact us at 732-235-7356.